ADMA BIOLOGICS INC Share Price Today: Live Updates & Key Insights

ADMA BIOLOGICS INC share price today is $14.37, up -4.66%. The stock opened at $15.2 against the previous close of $15.02, with an intraday high of $15.2 and low of $14.24.

ADMA BIOLOGICS INC Share Price Chart

ADMA BIOLOGICS INC

us-stock
To Invest in {{usstockname}}
us-stock

ADMA BIOLOGICS INC Share Price Performance

$14.37 -0.0466(-4.66%) ADMA at 23 Mar 2026 11:53 AM Biotechnology
Lowest Today 14.24
Highest Today 15.2
Today’s Open 15.2
Prev. Close 15.02
52 Week High 25.67
52 Week Low 13.76
Day’s Range: Low 14.24 High 15.2
52-Week Range: Low 13.76 High 25.67
1 day return -
1 Week return -9.59
1 month return -11.93
3 month return -27.93
6 month return -10.66
1 year return -29.49
3 year return +378.13
5 year return +588.46
10 year return -

ADMA BIOLOGICS INC Institutional Holdings

BlackRock Inc 14.96

Vanguard Group Inc 8.76

iShares Core S&P Small-Cap ETF 6.05

State Street Corp 5.69

Amvescap Plc. 5.25

Sachem Head Capital Management LP 4.78

Vanguard Total Stock Mkt Idx Inv 3.02

Westfield Capital Management Company, L.P. 2.94

Capital Research Global Investors 2.79

Nuveen, LLC 2.49

Geode Capital Management, LLC 2.45

iShares Russell 2000 ETF 2.37

American Funds SMALLCAP World A 2.22

American Century Companies Inc 2.18

State Street® SPDR® S&P® Biotech ETF 2.05

Dimensional Fund Advisors, Inc. 2.03

Thrivent Financial For Lutherans 1.59

American Century Small Cap Growth Inv 1.33

American Century U.S. Small Cap Growth 1.33

Caligan Partners LP 1.26

The Goldman Sachs Group Inc 1.22

Franklin Resources Inc 1.19

Vanguard Institutional Extnd Mkt Idx Tr 1.08

Vanguard Small Cap Index 1.08

B Group, Inc 1.03

Northern Trust Corp 0.99

Thrivent Small Cap Stock A 0.98

Invesco Main Street Small Cap R6 0.98

Invesco Small Cap Core 0.98

CREF Total Global Stock Account R3 0.97

Ranger Investment Management LP 0.97

Fidelity Small Cap Index 0.95

Charles Schwab Investment Management Inc 0.95

State Street SPDR Port S&P 600 Sm CpETF 0.93

Awm Investment Company Inc 0.92

iShares S&P Small-Cap 600 Growth ETF 0.85

iShares Russell 2000 Growth ETF 0.82

Ranger Small Cap 0.77

Putnam Small Cap Growth A 0.75

iShares Biotechnology ETF 0.72

ADMA BIOLOGICS INC Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

ADMA BIOLOGICS INC Fundamentals

Market Cap 3410.44 M

PB Ratio 7.4942

PE Ratio 23.8667

Enterprise Value 3569.41 M

Total Assets 624.24 M

Volume 10048166

ADMA BIOLOGICS INC Company Financials

Annual Revenue FY25:510173000 510.2M, FY23:234292778 234.3M, FY22:154079692 154.1M, FY21:80942625 80.9M, FY20:42219783 42.2M

Annual Profit FY25:292765000 292.8M, FY23:72032654 72.0M, FY22:35265157 35.3M, FY21:1173284 1.2M, FY20:-19071643 -19.1M

Annual Net worth FY25:146930000 146.9M, FY23:-22826150 -22.8M, FY22:-85183323 -85.2M, FY21:-84452877 -84.5M, FY20:-87605086 -87.6M

Quarterly Revenue Q4/2025:139163000 139.2M, Q3/2025:134224000 134.2M, Q2/2025:121984000 122.0M, Q1/2025:114802000 114.8M, Q3/2024:119839000 119.8M

Quarterly Profit Q4/2025:88816000 88.8M, Q3/2025:75626000 75.6M, Q2/2025:67227000 67.2M, Q1/2025:61097000 61.1M, Q3/2024:59659000 59.7M

Quarterly Net worth Q4/2025:49379000 49.4M, Q3/2025:36428000 36.4M, Q2/2025:34219000 34.2M, Q1/2025:26904000 26.9M, Q3/2024:35909000 35.9M

About ADMA BIOLOGICS INC & investment objective

Company Information ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Organisation Biotechnology

Employees 640

Industry Biotechnology

CEO Mr. Adam S. Grossman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ADMA BIOLOGICS INC FAQs

What is the share price of ADMA BIOLOGICS INC today?

The current share price of ADMA BIOLOGICS INC is $14.37.

Can I buy ADMA BIOLOGICS INC shares in India?

Yes, Indian investors can buy ADMA BIOLOGICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ADMA BIOLOGICS INC shares in India?

You can easily invest in ADMA BIOLOGICS INC shares from India by:

Can I buy fractional shares of ADMA BIOLOGICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ADMA BIOLOGICS INC?

ADMA BIOLOGICS INC has a market cap of $3410.44 M.

In which sector does ADMA BIOLOGICS INC belong?

ADMA BIOLOGICS INC operates in the Biotechnology sector.

What documents are required to invest in ADMA BIOLOGICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ADMA BIOLOGICS INC?

The PE ratio of ADMA BIOLOGICS INC is 23.87 and the PB ratio is 7.49.